Wednesday, March 14, 2018 10:50:56 AM
Jane
OUT OF MY WAY......I NEED A LATTE
Recent DERM News
- Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights • GlobeNewswire Inc. • 03/21/2024 08:01:27 PM
- Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea • GlobeNewswire Inc. • 03/18/2024 12:30:30 PM
- Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024 • GlobeNewswire Inc. • 03/15/2024 12:30:01 PM
- Journey Medical Corporation to Participate in the 36th Annual ROTH Conference • GlobeNewswire Inc. • 03/13/2024 12:30:14 PM
- Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting • GlobeNewswire Inc. • 03/11/2024 12:30:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:54:53 PM
- Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea • GlobeNewswire Inc. • 01/05/2024 01:30:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 09:05:34 PM
- Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million • GlobeNewswire Inc. • 01/02/2024 09:05:30 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 12/15/2023 09:46:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2023 10:01:17 PM
- Journey Medical Corporation Announces Successful Completion of Pre-NDA Meeting with the FDA for DFD-29 to Treat Rosacea • GlobeNewswire Inc. • 12/06/2023 01:00:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 09:45:43 PM
- Journey Medical Corporation Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights • GlobeNewswire Inc. • 11/07/2023 09:01:18 PM
- Journey Medical Corporation to Announce Third Quarter 2023 Financial Results on November 7, 2023 • GlobeNewswire Inc. • 10/31/2023 12:30:12 PM
- Journey Medical Corporation Announces Data from Bioavailability Study of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) vs. Solodyn® (Minocycline Hydrochloride Extended-Release Tablets, 105 mg) • GlobeNewswire Inc. • 10/20/2023 12:30:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/17/2023 08:01:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2023 01:10:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2023 08:59:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/08/2023 05:26:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2023 12:00:22 PM
- Journey Medical Corporation Enters into an Exclusive License Agreement with Maruho Co., Ltd. for Qbrexza® in South Korea and Other Asian Nations • GlobeNewswire Inc. • 09/06/2023 12:00:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/18/2023 09:00:17 PM
- Fortress Biotech Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights • GlobeNewswire Inc. • 08/14/2023 08:01:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:45:50 PM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM